binimetinib,Encorafenib,Entrectinib,sotorasib,Adagrasib,Cetuximab,Afatinib,Pembrolizumab,olaparib,Larotrectinib,Seribantumab,Zenocutuzumab,pralsetinib,Trastuzumab deruxtecan
ono Pharmaceuticalscueticals,pierre fabre,pfizer,roche,Amgen,Mirati,Eli Lilly,Boehringer Ingelheim,Merck,Astrazeneca,Bayer,elevation oncology,sanofi,Merus,Blueprint Medicines,Roche,Daiichi Sankyo,Astrazeneca
['pancreatic']
i am bookmarking this slide on targeted therapies in pancreatic cancers, presented by . remains a hard-to-treat disease, but don t miss the options that are available! #esmo22 
Clinician/Scientist with a passion for hepato-oncology and basic science. Member of the EASL YI Task Force, EASL social media ambassador #LiverTwitter